Immunomodulatory activity of electrospun polyhydroxyalkanoate fiber scaffolds incorporating olive leaf extract by De la Ossa, J.G. et al.
This is a repository copy of Immunomodulatory activity of electrospun 
polyhydroxyalkanoate fiber scaffolds incorporating olive leaf extract.




De la Ossa, J.G., Fusco, A., Azimi, B. et al. (10 more authors) (2021) Immunomodulatory 
activity of electrospun polyhydroxyalkanoate fiber scaffolds incorporating olive leaf extract. 





This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 




Immunomodulatory Activity of Electrospun
Polyhydroxyalkanoate Fiber Scaffolds Incorporating Olive
Leaf Extract
Jose Gustavo De la Ossa 1,2, Alessandra Fusco 3,4 , Bahareh Azimi 3,5, Jasmine Esposito Salsano 1,6 ,
Maria Digiacomo 6,7 , Maria-Beatrice Coltelli 3,5 , Karen De Clerck 8 , Ipsita Roy 9 , Marco Macchia 6,7,
Andrea Lazzeri 5 , Giovanna Donnarumma 3,4 , Serena Danti 5,* and Rossella Di Stefano 2,7


Citation: De la Ossa, J.G.; Fusco, A.;
Azimi, B.; Esposito Salsano, J.;
Digiacomo, M.; Coltelli, M.-B.; De
Clerck, K.; Roy, I.; Macchia, M.;
Lazzeri, A.; et al. Immunomodulatory
Activity of Electrospun
Polyhydroxyalkanoate Fiber Scaffolds
Incorporating Olive Leaf Extract.
Appl. Sci. 2021, 11, 4006. https://
doi.org/10.3390/app11094006
Academic Editor: Oleh Andrukhov
Received: 26 March 2021
Accepted: 25 April 2021
Published: 28 April 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Doctoral School in Life Sciences, University of Siena, 53100 Siena, Italy;
josegustavo.delao@student.unisi.it (J.G.D.l.O.); ja.espositosalsano@student.unisi.it (J.E.S.)
2 Cardiovascular Research Laboratory, Department of Surgical, Medical and Molecular Pathology and Critical
Care Medicine, University of Pisa, 56126 Pisa, Italy; rossella.distefano@unipi.it
3 Consorzio Interuniversitario Nazionale per la Scienza e Tecnologia dei Materiali (INSTM),
50121 Florence, Italy; alessandra.fusco@unicampania.it (A.F.); b.azimi@ing.unipi.it (B.A.);
maria.beatrice.coltelli@unipi.it (M.-B.C.); giovanna.donnarumma@unicampania.it (G.D.)
4 Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy
5 Department of Civil and Industrial Engineering, University of Pisa, 56122 Pisa, Italy; andrea.lazzeri@unipi.it
6 Department of Pharmacy, University of Pisa, 56126 Pisa, Italy; maria.digiacomo@unipi.it (M.D.);
marco.macchia@unipi.it (M.M.)
7 Interdepartmental Research Center “Nutraceuticals and Food for Health”, University of Pisa, 56100 Pisa, Italy
8 Centre for Textile Science and Engineering, Department of Materials, Textiles and Chemical Engineering,
University of Gent, 9000 Gent, Belgium; Karen.DeClerck@UGent.be
9 Department of Materials Science & Engineering, Kroto Research Institute, University of Sheffield,
Sheffield S10 2 TG, UK; i.roy@sheffield.ac.uk
* Correspondence: serena.danti@unipi.it
Featured Application: We produced polyhydroxyalkanoate (PHA) ultrafine fiber meshes incorpo-
rating olive leaf extract (OLE), which is rich in polyphenols entitled with antioxidant activity. The
unique PHA chemistry, small size and surface topography of electrospun fibers, together with
OLE, showed immunomodulatory properties towards skin keratinocytes in vitro. OLE/PHA fiber
meshes showed promise for application as tissue engineering dressings in chronic wound repair.
Abstract: Olive tree is a well-known source of polyphenols. We prepared an olive leaf extract (OLE)
and characterized it via high performance liquid chromatography (HPLC) analysis. OLE was blended
with different polyhydroxyalkanoates (PHAs), namely, poly(hydroxybutyrate-co-hydroxyvalerate)
(PHBHV) and polyhydroxybutyrate/poly(hydroxyoctanoate-co-hydroxydecanoate) (PHB/PHOHD),
to produce fiber meshes via electrospinning: OLE/PHBV and OLE/ (PHB/PHOHD), respectively.
An 80–90% (w/w%) release of the main polyphenols from the OLE/PHA fibers occurred in 24 h, with
a burst release in the first 30 min. OLE and the produced fiber meshes were assayed using human
dermal keratinocytes (HaCaT cells) to evaluate the expression of a panel of cytokines involved in
the inflammatory process and innate immune response, such as the antimicrobial peptide human
beta defensin 2 (HBD-2). Fibers containing OLE were able to decrease the expression of the pro-
inflammatory cytokines at 6 h up to 24 h. All the PHA fibers allowed an early downregulation of
the pro-inflammatory cytokines in 6 h, which is suggestive of a strong anti-inflammatory activity
exerted by PHA fibers. Differently from pure OLE, PHB/PHOHD fibers (both with and without
OLE) upregulated the expression of HBD-2. Our results showed that PHA fiber meshes are suitable
in decreasing pro-inflammatory cytokines and the incorporation of OLE may enable indirect antibac-
terial properties, which is essential in wound healing and tissue regeneration.
Appl. Sci. 2021, 11, 4006. https://doi.org/10.3390/app11094006 https://www.mdpi.com/journal/applsci
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1. Introduction
Olive tree (i.e., Olea europaea) is one of the most ancient trees of the Mediterranean area.
By virtue of its properties, olive tree derivatives have been employed in traditional medicine
as botanical drugs and food supplements. In particular, olive leaf extract (OLE) has been
considered for different purposes [1], for example, as an antihypertensive, antiatherogenic,
anti-inflammatory, hypoglycemic or hypocholesterolemic agent [2–4]. In fact, OLE is known
to be a good source of antioxidants, bioactive compounds, even including polyphenols [5,6].
Among them, the secoiridoid oleuropein is the main component of OLE, in addition to
other secoiridoids derived from tyrosol structures and flavonoids. The nutraceutical
properties of OLE have been attributed to secoiridoid oleuropein and its derivatives, such
as hydroxytyrosol [7]. Polyphenol concentration in OLE may depend on the geographical
position, type of cultivar, age of the olive tree and collection season [8,9].
In recent years, polyphenols have shown a broad range of biological activities, includ-
ing anti-inflammatory and immunomodulatory actions, demonstrated both in vitro and
in vivo, along with a beneficial role in many acute and chronic disorders [10–13]. Inflam-
mation is generally defined as a response of vascularized living tissue to local injury, often
induced by exogenous factors, such as pathogen aggression. The inflammatory process
indeed serves to neutralize, dilute or wall off the injurious agent and promotes immune
cell recruitment. In addition, endogenous factors, e.g., cancer, diabetes, arthritis, neu-
rodegenerative diseases and cardiovascular issues, among others, concur to establish and
sustain the inflammatory processes. According to many epidemiological and experimental
research activities of dietary polyphenols, OLE displays the ability, proper of these natural
compounds, to act on pro-inflammatory genes that encode several cytokines, in addition to
their antioxidant characteristics, such as reactive oxygen species (ROS) scavenging, which
overall contribute to the regulation of inflammatory pathway [9,14]. Chronic inflammation
occurs when an inflammatory event is not resolved and is characterized by the presence of
several immune cell types, such as macrophages, monocytes and lymphocytes. It is impor-
tant to mention that a type of immune cells, the macrophages, have been demonstrated to
be affected by polyphenols [15]. Upon skin damage, epidermis response leads the immune
reaction by the production of pro-inflammatory, anti-inflammatory and antimicrobial (i.e.,
defensin) molecules by keratinocytes, which do play a role in skin immunomodulation. To
repair a chronically inflamed wound, dressings are usually applied to protect and enable
the healing of the wound [16]. Considering the prominent role of OLE in modulating the
inflammation, it is proposed the use of new biomaterials incorporating OLE in wound
healing. In this process, injured epithelial cells can trigger the inflammatory response and
ultimately modulate it [17].
Among the variety of biocompatible and biodegradable polymers, polyhydroxyalka-
noates (PHAs), are an emerging class of biopolyesters synthesized by various microorgan-
isms as lipid inclusions stored within cells [18]. PHAs are a wide family of polymers and
copolymers; as such, they possess diverse chemical structure, which results in a diversified
range of material properties, thus showing a tunable drug delivery behavior [19]. Among
PHAs, poly(hydroxybutyrate-co-hydroxyvalerate) (PHBHV) copolymer has largely been
investigated in the biomedical field as it shows great potential for fabricating biomedical
micro- and nano- drug carriers [20]. Electrospinning is simple method to obtain meshes
of ultrafine fibers, whose size falls in the order of 1–2 microns down to 10 nanometers.
Such tiny fibers mimic the fibrous arrangement of the extracellular matrix (ECM). Via
electrospinning, scaffolds result typically assembled into nonwoven networks, which are
deposited in random or aligned fiber orientation [21]. Overall, both OLE and PHAs are
bio-based materials that comply with the circular economy and green chemistry, as OLE
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extraction can be water based, and the electrospinning process usually is performed at
room temperature [9,16,21–23].
In this study, after characterization of polyphenol content in OLE, two types of PHA
fiber meshes incorporating OLE were produced via electrospinning and proposed as
wound dressings. In particular, we used commercially available PHBHV and a blend of
polyhydroxybutyrate (PHB) and poly(hydroxyoctanoate-co-hydroxydecanoate) (PHOHD)
produced and characterized in laboratory. The release of OLE from PHA fibers was evalu-
ated. To assess the biological effects of the new products in vitro, we used human dermal
keratinocytes (HaCaT cell line) and investigated a panel of interleukins (ILs) involved in
the inflammatory and immune response.
Developing fully bio-based scaffolds provided with immunomodulatory properties
would improve the management of wounds and in particular chronic wounds.
2. Materials and Methods
2.1. Materials
Acetic acid, acetonitrile (ACN), methanol (MeOH), sodium carbonate (Na2CO3) were
purchased from Sigma-Aldrich (Milan, Italy). The following commercial compound as
analytical standards are used: gallic acid, oleuropein and p-hydroxyphenylacetic acid, pur-
chased from Sigma-Aldrich (Milan, Italy); tyrosol, hydroxytyrosol, caffeic acid, p-coumaric
acid, purchased from TCI (Zwijndrecht, Belgium); luteolin-7-O-glucoside, apigenin-7-
O-glucoside and rutin, purchased from Extrasynthese (Lyon, France). Folin–Ciocalteu
reagent was purchased from Merk (Darmstadt, Germany). Phosphate-buffered saline
(PBS) was purchased from Sigma-Aldrich (Milan, Italy) and for each analysis was diluted
10 times. Chloroform (code: 102442), 2-butanol (code: 109630), lithium bromide (LiBr2),
acetic acid (code: 33209), ethanol (EtOH), PHBHV (HV content 12% w/v) and Dulbecco’s
phosphate-buffered saline (DPBS) were provided by Sigma-Aldrich (Milan, Italy). Im-
mortalized human keratinocytes, HaCaT cell line was purchased from CLS—Cell Lines
Service, Eppelheim, Germany. MgCl2, Dulbecco’s Modified Essential Medium (DMEM),
L-glutamine, penicillin, streptomycin and fetal calf serum were purchased from Invitrogen,
(Carlsbad, CA, USA). AlamarBlue was bought from Thermo Fisher Scientific (Waltham,
MA, USA). LC Fast Start DNA Master SYBR Green kit was obtained from Roche Applied
Science (Euroclone S.p.A., Pero, Italy). P(3HB) and P(3HO-3HD) were supplied by Roylab,
University of Sheffield, UK.
2.2. OLE Extraction
Olive leaves were obtained from Olivastra seggianese plantation located at CNR-
IVALSA, Follonica (GR), Italy. Leaf collection was manually performed in May 2019.
Following liquid nitrogen freezing and hand-made crushing, the leaves powder was added
with water and sonicated followed by vortex mixing. After centrifugation at 4000 rpm for
5 min, at 25 ◦C, the water phase was filtered and freeze-dried obtaining OLE.
2.3. OLE Characterization
A high-performance liquid chromatography analysis (HPLC) was carried out to
identify and quantify the major phenolic compounds of the OLE using a slightly modified
method developed in a previous study [24]. The retention times and UV absorbance spectra
of phenolic compounds present in OLE were compared with those of the commercial
standard and quantified at 278 nm, using p-hydroxyphenyl acetic acid as the internal
standard, according to the previously reported method [9]. Sample concentrations were
determined by linear regression. For each calibration curve, the correlation coefficients
were >0.99. HPLC analysis was performed with a HPLC instrument (Thermo Finnigan-
Spectra System SCM1000) equipped with a Spectra System P2000 (Pumps), Spectra System
UV2000, set to 280 nm, and using a Phenomenex Gemini reverse-phase C18 column
(250 × 4.6 mm, 5 µm particle size; Phenomenex, Castel Maggiore, Italy). The mobile phase
was a mixture of H2O/acetic acid (97.5:2.5 v/v) (A) and ACN (B). A linear gradient was run
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from 5% (B) to 25% (B) in 20 min; it changed to 50% (B) during 20 min (40 min total time);
in 10 min it changed to 80% (B) (50 min total time), after re-equilibration in 5 min (55 min,
total time) to initial composition. The flowrate was 1 mL/min, and the injected volume
was 50 µL. Samples were injected as a mixture of methanol/PBS (1:1 v/v). To assess the
phenol content, 10 mg of OLE powder was dissolved in PBS and therefore analyzed with
HPLC. The amount of phenolic compounds incorporated inside the polymer fibers was
investigated using 4 cm2 square meshes dissolved in MeOH, and the resulting solution
was analyzed by HPLC.
The total phenolic (TP) content was determined using the Folin–Ciocalteu method and
gallic acid as the standard equivalent (ug GAE /mg), following a reported procedure [25].
About 10 mg of OLE were dissolved in 10 mL of CH3OH-H2O (80:20 v/v), and then, an
aliquot of this solution (1 mL) was mixed with 0.25 mL of Folin–Ciocalteu reagent and
1.5 mL of Na2CO3 (20% w/v). After purified water was added to reach the volume of
10 mL, the resulting mixture was kept for 45 min at the controlled temperature of 25 ◦C.
Spectrophotometric analysis was performed at λ = 725 nm.
2.4. Scaffold Fabrication
PHAs were used to prepare blends with OLE to be processed via electrospinning: (a)
commercial PHBHV and (b) a blend of P(3HB)/P(3HO-3HD) (laboratory made). Different
solutions were set up for optimizing PHA the electrospinning process (Linari Engineering
s.r.l, Pisa, Italy): (1) PHBHV was dissolved in a dichloromethane/methanol (10:1 w/w)
mixture at 15% w/w.; (2) P(3HO-3HD)/(PHB) 10:1 (w/w) was dissolved in chloroform/2-
butanol (7:3 w/w) mixture and 0.002 g/mL LiBr at 11% w/w. OLE (16.8 w%) was added
to both solutions. Parameters of electrospinning were 40 kV, 0.5 mL/h flow rate and a
distance from needle tip (ground charge) to static aluminum collector (positive charge) of
40 cm for 1 h. Humidity was maintained at 40% and temperature 20 ◦C throughout.
2.5. Phenol Release
To investigate the release of phenols from the fibers, the diffusion of phenolic com-
pounds in PBS as a release medium was determined. A 4 cm2 square-shaped PHBHV/OLE
was inserted into a 3 cm diameter well of a multi-well plate, and 2 mL of PBS was added to
each well. Then, the plate containing the solutions was incubated in an oven at a controlled
temperature of 37 ◦C. At defined time intervals (i.e., 0, 0.5, 1, 1.5, 3, 4, 6, 24 h) medium
was removed, the well was washed with 1 mL of PBS, and an equal amount of the fresh
medium (2 mL) was replaced each time [26,27]. The qualitative-quantitative evaluation of
the phenols released from the fiber was carried out by HPLC analysis.
2.6. Epidermal Cell Culture and Metabolic Assay
Immortalized human keratinocytes (HaCaT cells) were cultured in DMEM supple-
mented with 1% Penstrep, 1% glutamine and 10% fetal calf serum inside a humidified
incubator set at 37 ◦C in air and 5% CO2. The HaCaT cells, seeded inside 12-well plates until
80% of confluence, were incubated for 24 h with the PHA fiber meshes or OLE alone and
considered as samples (s). Control experiments (c) were performed by adding the dye in
well plates without the cells. At the end of this time, AlamarBlue dye was added according
to the manufacturer’s instructions and incubated for 4 h. The monolayer cultures received
the same amount of OLE present in the OLE/PHA counterparts, which was calculated
by weighting the OLE/PHA samples. The absorbance (λ) of supernatants was measured
with a spectrophotometer (Victor 3; PerkinElmer, Waltham, MA, USA) under a double
wavelength reading (570 nm and 600 nm). Finally, the dye reduction percentage (%ABred)
was calculated correlating the absorbance values and the molar extinction coefficients of
the dye at the selected wavelengths, following the protocol provided by the manufacturer.
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The equation (Equation (1)) applied is shown below, in which: λ = absorbance, s = sample,
and c = control:
%ABred = 100·
(
117,216·λs(570 nm) − 80,586·λs(600 nm)
)
(
155,677·λc(600 nm) − 14,652·λc(570 nm)
) (1)
2.7. Evaluation of Immunomodulatory Properties
The immunomodulatory properties were assayed using HaCaT cell line. The cells,
cultured as described above, seeded inside 12-well plates until 80% of confluence, were
incubated with the PHA fiber meshes for 6 and 24 h (n = 3). At these endpoints, total RNA
was isolated with TRizol, and 1 µm of RNA was reverse-transcribed into complementary
DNA (cDNA) using random hexamer primers, at 42 ◦C for 45 min, according to the
manufacturer’s instructions. Real time polymer chain reaction (PCR) was carried out with
the LC Fast Start DNA Master SYBR Green kit using 2 µL of cDNA, corresponding to 10 ng
of total RNA in a 20 µL final volume, 3 mM MgCl2 and 0.5 µM sense and antisense primers
(Table 1). Real-Time PCR was used to evaluate the expression of IL-1α, IL 1β, IL-6, IL-8,
tumor necrosis factor alfa (TNF-α) and transforming growth factor beta (TGF-β).
Table 1. Real-time PCR primer sequence and operating conditions for HaCaT cells.
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10 s at 72 ◦C for 50 cycles
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2.8. Statistical Analysis
Statistical analysis was carried out by SPSS (SPSS v.21.0; IBM) and shown as mean ±
standard deviation (SD). For PCR analysis, each marker expression level was compared
against its untreated control using Student’s t-test. Probability (p) values < 0.05 were
considered as statistically significant differences.
3. Results
3.1. OLE Characterization
The TP content of OLE was estimated via the Folin–Ciocalteu method, resulting in
58.47 µg GAE/mg. Furthermore, HPLC analysis allowed to determine the main phenolic
compounds present in OLE, which were oleuropein and luteolin-7-O-glucoside, with a
concentration of 32.64 ± 3.06 mg/g of OLE and 6.97 ± 0.24 mg/g of OLE, respectively. In
addition, we detected apigenin-7-O-glucoside with a concentration of 1.97 ± 0.17 mg/g of
OLE, rutin with a concentration of 3.37 ± 0.33 mg/g of OLE and other compounds, such as
hydroxytyrosol, caffeic acid and p-coumaric acid, with concentrations lower than 1 mg/g
of OLE (Figure 1).














Figure 1. Bar graph showing the content (mg/g) of different phenolic compounds detected in OLE.
3.2. Morphological Characterization of PHA Fiber Meshes

















Figure 2. SEM micrographs of electrospun PHA fibers: (a,b) PHBHV (commercial), and (c,d)
PHB/PHOHD (from Roy’s laboratory); (a,c) plain PHAs, and (b,d) PHAs incorporating OLE. Original
magnification 1000× (scale bar 100 µm). Lens show details of the fibers (scale bar 30 µm).
3.3. Polyphenol Release from PHA Fibers
The phenolic content of PHBHV/OLE was analyzed. The results of HPLC analysis
indicated that the amount of main phenols present was 21.84 ± 0.14 µg for oleuropein,
7.22 ± 0.78 µg for luteolin-7-O-glucoside and 3.54 ± 0.13 µg for apigenin-7-O-glucoside.
Subsequently, we have evaluated the release profile of these polyphenols (oleuropein,
luteolin-7-O-glucoside and apigenin-7-O-glucoside) from fiber. The quantity of these
released phenolic compounds during the submersion time (24 h), as shown in Figure 3,
was expressed as percentage of initial amount.
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Figure 3. Graph showing the cumulative release (w/w%) of the three main OLE polyphenols from
PHBHV/OLE fiber meshes during 24 h. The released quantities after 6 h reached 90% (w/w%) for
oleuropein, and 80% (w/w%) for luteolin-7-O-glucoside and apigenin-7-O-glucoside. The highest
release is observed for all polyphenols during the first 30 min.
At the first 30 min, the amount of oleuropein released was about 60% of the total
oleuropein content in the fiber. Then the release became more gradual, reaching about
90% after 6 h. Luteolin-7-O-glucoside and apigenin-7-O-glucoside after the first 30 min
were released about 40% and 30%, respectively, with respect to the initially loaded quantity
in the fibers, reaching about 80% after 6 h in both cases. Chromatograms are reported in
Supplementary Materials (Figures S1–S3).
3.4. Cell Metabolic Activity
Results of metabolic activity (AlamarBlue test) performed using human dermal ker-
atinocytes (HaCaT cells) after 24 h showed that all the samples had dye reduction percent-
age (%ABred) above 70%, and remarkable differences among the fiber samples were not
revealed (Table 2). Pure OLE, tested in monolayer (i.e., without the fibers) cultures showed
increased metabolic activity in these cells if compared to the fiber samples. Overall, these
results confirmed the good cytocompatibility of the PHAs and OLE.











%ABred 74% 77% 76% 75% 94%
3.5. Cytokine Expression
The results for the different pro-inflammatory ILs, expressed at mRNA level from
HaCaT cells in contact with the scaffolds as well as pure OLE after 6 and 24 h, are reported in
Figures 4–7. OLE alone was administrated to the cells in standard culture (namely, without
fibers) using the same dose loaded in 1 cm2 of fibers. Figure 4 shows the expression of IL-1
(α and β isoforms) by HaCaT cells in contact with the different PHA fibers and with OLE
up to 24 h. Comparing to the basal expression conditions of HaCaT cells, both IL-1α and
IL-1β expressions were significantly downregulated by all the fibers in 6 h, independently
of OLE incorporation. OLE alone was able to modulate IL-1α and IL-1β expression in 24 h,
showing statistical significance in IL-1β (p < 0.05). The specific action of OLE in long term
(24 h) downregulation of IL-1β was observed in OLE/P(PHB/PHOHD) fibers (p < 0.05).
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Figure 4. Bar graphs showing IL-1 expression by HaCaT cells at 6 and 24 h: IL-1α, and IL-1β.
Comparisons between samples were analyzed by Student’s t-test. Data are mean ± SD and are
expressed as percentage of increment relative to untreated cells (used as controls). Significant
differences are indicated by * (p < 0.05), ** (p < 0.01) and *** (p < 0.001) for comparison between each
sample and its respective control.
α
Figure 5. Bar graph showing IL-6 expression by HaCaT cells at 6 and 24 h. Comparisons between
samples were analyzed by Student’s t-test. Data are mean ± SD and are expressed as percentage of
increment relative to untreated cells (used as controls). Significant differences are indicated by * (p < 0.05),
** (p < 0.01) and *** (p < 0.001) for comparison between each sample and its respective control.
α
Figure 6. Bar graph showing IL-8 expression by HaCaT cells at 6 and 24 h. Comparisons between
samples were analyzed by Student’s t-test. Data are mean ± SD and are expressed as percentage of
increment relative to untreated cells (used as controls). Significant differences are indicated by * (p < 0.05),
** (p < 0.01) and *** (p < 0.001) for comparison between each sample and its respective control.
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α
Figure 7. Bar graph showing TNF-α expression by HaCaT cells at 6 and 24 h. Comparisons between
samples were analyzed by Student’s t-test. Data are mean ± SD and are expressed as percentage
of increment relative to untreated cells (used as controls). Significant differences are indicated by
* (p < 0.05) for comparison between each sample and its respective control.
The expression of IL-6 is displayed in Figure 5. IL-6 resulted to be strongly downregu-
lated by all the PHA fiber formulations with statistical significance (all p < 0.05). OLE alone
did not significantly changed the IL-6 expression level at 6 and 24 h with respect to the
basal expression level of HaCaT cells (p = n.s.). A specific effect of OLE incorporation in
the fibers could not be revealed for IL-6 expression.
The outcomes of IL-8 expression are reported in Figure 6. Moreover, in this case, a
strong downregulation of this cytokine was exerted by all the fibers independently of OLE
incorporation (all p < 0.05). Differently, OLE alone caused a marked upregulation after 6 h
(p < 0.05), which was still significant after 24 h (p < 0.01).
The results of TNF-α expression are shown in Figure 7. In a similar fashion to the
findings reported for the other cytokines, all the PHA fibers downregulated the expression
of TNF-α independently of OLE incorporation. Plain OLE was also able to downregulate
the expression of this pro-inflammatory cytokine at 24 h (p < 0.05).
Finally, TGF-β was not modulated by any PHA and/or OLE formulation tested in
this study (data not shown).
3.6. Indirect Antimicrobial Activity
The expression of the antimicrobial peptide HBD-2 is reported in Figure 8.
Figure 8. Bar graph showing HBD-2 expression by HaCaT cells at 6 and 24 h. Comparisons between
samples were analyzed Student’s t-test. Data are mean ± SD and are expressed as percentage of
increment relative to untreated cells (used as controls). Significant differences are indicated by
* (p < 0.05) and ** (p < 0.01) for comparison between each sample and its respective control.
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In this case, it was observed that only two PHB/PHOHD fiber formulations were able
to promote the upregulation of HBD-2 with statistical significance, after 6 h, specifically
PHB/PHOHD containing OLE (p < 0.05) and plain PHB/PHOHD (p < 0.01). OLE/PHBHV
was able to increase the expression of this peptide without statistical significance after 6 h.
OLE alone, at the same concentrations, did not show any effect on HaCaT cells.
4. Discussion
Chronic wounds result from a widespread group of pathologies, including, among
others, ulcers from diabetic, vascular and pressure diseases [28]. Such wounds still rep-
resent a healthcare challenge around the globe by affecting several millions of people, as
they remain unhealed for months or years. Even if the underlying pathologies play a key
role in wound establishment and perpetuation, chronic wounds possess some common
features, defined as “prolonged or excessive inflammation, persistent infections, formation of
drug-resistant microbial biofilms, and the inability of dermal and/or epidermal cells to respond
to reparative stimuli” [28]. The possibility of modulating the inflammatory processes and
improving the self-defense towards microorganisms can thus facilitate a more efficient
regeneration operated by skin cells. Dressings are usually applied at the wound site to
enable protection, homeostasis and absorb exudate if needed [29]. The modern wound
dressings also aim to facilitate the reparatory processes by releasing growth factors or
providing material-intrinsic antimicrobial properties [30].
Bioresorbable natural-origin materials offer remarkable opportunities in this field; in
fact, if these biomaterials are spun into micrometric or submicrometric fibers, a structure
similar to the fibrous components of ECM is provided for the neighboring cells to repair
a wound [16]. To this purpose, biomaterial scaffolds stimulating immunomodulatory
and antimicrobial activity in the skin cells, would offer a relevant alternative to current
treatments. We hypothesized that the polyphenols present in OLE could provide a bene-
ficial role in skin immunomodulation and that their presence in a fibrous dressing could
promote their function by means of a better controlled local release to the cells within/from
a three-dimensional (3D) structure.
We considered a novel family of polyesters, i.e., PHAs, as a bio-based polymer source
to produce ultrafine fiber nonwovens via electrospinning. Previous studies with plain
PHAs confirmed the good electro-spinnability of these polymers [31–33]. In this study, by
using identical solvents and solution parameters, two types of fiber mesh were obtained:
one based on commercial PHBHV and one based on a blend of two laboratory-produced
PHAs, i.e., PHB/PHOHD, which were previously tested under distinct electrospinning
modalities and apparatus [31–33]. Both of them were loaded with the same amount of
OLE and used for in vitro tests performed using human dermal keratinocytes (HaCaT
cells). We observed that the presence of OLE differently affected the final architecture of
two PHA formulations, by favoring the formation of beads and molten fibers in particular
in the PHB/PHOHD nonwovens. In electrospun manufacts, beads are considered as
morphological defects due to nonoptimal electrospinning conditions, as the fiber diameter
is not consistent along fiber length [34]. Beads result to strongly depend on surface tension,
and solvents or additives can help to reduce this phenomenon [35]. However, it has been
reported that in case of fibrous meshes loaded with bioactive agents, beaded structures
can act as mini-reservoirs of the drug, thus enabling a better tunable delivery [36]. Similar
to other parts of the olive tree, OLE contains considerable amounts of polyphenols [37];
among them, oleuropein is the key phenolic compound found in unprocessed olive fruits
and also in leaves, where it reaches about 60–90 mg/g (dry weight) [38].
The well-known antioxidant activity of oleuropein is manifold: it directly relies on its
chemical structure owning an ortho-diphenolic group able to scavenge reactive oxygen
species (ROS) via hydrogen donation and to stabilize oxygen radicals via an intramolecular
hydrogen bond. In addition, oleuropein provides an indirect antioxidant activity by stimu-
lating the expression of intracellular antioxidant enzymes and increasing the level of nonen-
zymatic antioxidant molecules [38]. Recently, the anti-inflammatory properties of olive
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products have also been investigated in relation to dietary food [39]. Chronic inflammation
is linked to ROS production causing oxidative damage and antioxidant depletion. As
such, some studies have investigated the influence of oleuropein on macrophages, the key
cells involved in inflammatory processes by producing ROS and other pro-inflammatory
cytokines, but further able to support healing by releasing anti-inflammatory cytokines,
if timely and properly differentiated [40–42]. In some studies, OLE is reported to show
direct antimicrobial activity, which was primarily attributed to its main polyphenols [43].
However, the findings available on the antibacterial properties of OLE are still debated, as
they may depend on extraction methods, polyphenol composition and quantity, including
dose, on selected bacteria; as such, combined technologies including for example OLE and
plasma can be needed [44].
In our study, we assayed the release of three main components of OLE, namely,
oleuropein, luteolin-7-O-glucoside and apigenin-7-O-glucoside from PHA fiber meshes.
Such polyphenols were almost totally released after 24 h, reaching oleuropein about 90%
and the two glucosides about 80% in 6 h. Unlike using systemic or even local injections, the
scaffold can promote a better confined delivery at the wound site by avoiding the dispersion
of the active principle through the blood vessels, thus keeping the drug concentration
locally higher [45]. In addition to OLE release, it is expected that the fiber meshes would
provide a suitable support for tissue regeneration. Since re-epithelization is a leading
phenomenon in skin repair, we investigated the viability of HaCaT cells by measuring their
metabolic activity on the different meshes, with or without OLE, including using OLE alone.
We observed that, when cultured on the fibrous scaffolds for 24 h, HaCaT cell metabolic
activity was very similar, independently of the type of fiber or OLE loading, whereas it
was higher when pristine OLE was added at the same amount. The difference of plain
OLE effect on cell metabolic activity can be explained by the subitaneous availability of the
bioactive ingredients with respect to a slower release operated by the fibers. However, it is
frequently observed that the presence of a three-dimensional substrate affects cell response
at early time-points, as adhesion phenomena and cell–cell interactions are more complex
events than in bi-dimensional tissue culture plastics [46,47].
In addition to macrophages, also epithelial cells, including skin keratinocytes, play a
fundamental role in innate immunity, being primarily exposed to injuries and inflamma-
tory stimuli. As such, epithelial cells contribute to healing by secreting several cytokines
and defensins [17]. As well as for metabolic activity, the administration of OLE alone or
mediated by PHA fibers after 24 h gave different outcomes in terms of cytokine expression
at mRNA level. Our results showed that all the PHA fiber samples were endowed with im-
munomodulatory properties. In fact, they were able to downregulate the pro-inflammatory
cytokines at 6 and 24 h, thus showing a suppressive function towards inflammation. Many
studies have reported that cell-biomaterial surface interaction is central in biocompatibility
as it rules the inflammatory process, including anti-fouling and antibacterial aspects [48].
Differently from the fiber samples, pure OLE displayed a role in the wound healing process,
by modulating the expression of the pro-inflammatory cytokines, which were upregulated
at 6 h and downregulated at 24 h. Wound healing is a complex process occurring via a
cascade of events such as inflammation, reepithelization, matrix formation, tissue repair
and remodeling. Two main phases drive this process: the first phase starts with the pro-
duction of pro-inflammatory cytokines. TNF-α and IL-1 represent the primary cytokines of
pro-inflammatory response, which are immediately released by keratinocytes upon wound
damage. TNF-α is an essential mediator of inflammation; it evokes several responses by the
vascular and coagulation systems which end up in recruiting immune cells and molecules
but may also cause tissue necrosis [49]. In addition, TNF-α is able to stimulate the produc-
tion of fibroblast growth factor (FGF), which can support reepithelization [50]. IL-1 has
two forms, namely, IL-1α and IL-1β, respectively produced by two different genes, with
structural homology of 30%, but analogous biological activity. At low doses, IL-1 promotes
local inflammation and coagulation. IL-1β is the best-known form; it activates an antimi-
crobial pattern on the neighboring epithelial cells, contributing to the upregulation of IL-6,
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which recruits and induces the differentiation of immune cells, and/or to the production of
IL-8, which ultimately contributes in regulating reepithelization, tissue remodeling and
angiogenesis [17,51,52]. The TGF-β is a powerful anti-inflammatory cytokine entitled with
different activities, both prohibitory and stimulatory. In our finding, it was not modulated
after 24 h by any tested compounds and materials.
Inflammation is described as an interaction of pro- and anti-inflammatory cytokines.
Usually, chronic wounds have high levels of pro-inflammatory cytokines and underlying
infections, conditions that self-sustain each other over long times, thus impeding the second
phase of the healing process [53,54]. We showed that all the produced PHA fibers, either
incorporating or not OLE, were able to strongly and persistently downregulate of hundred-
fold differences the expression of all the above cited ILs, with respect to the basal conditions
of HaCaT cells in conventional culture. It is possible that this particular polymer class, i.e.,
PHAs, and the architecture of the ultrafine fibrous meshes both concurred to mimic the
fibrous ECM of dermal tissue produced by fibroblasts. In fact, it has been demonstrated
that the smaller diameter fiber (e.g., micro-nano size) scaffolds the lesser immune response
by macrophages using electrospun fibers of another polyester, the polylactide acid [55].
Regarding OLE alone, Liu et al. indicated that OLE showed a remarkable inhibitory
effect on the growth of several food pathogens when administrated at 62.5 mg/mL OLE
or 25 mg/mL oleuropein [39]. In our findings, the direct antibacterial effect of OLE at
100 mg/mL may still be insufficient [44]. Due to the high volume-to-surface area and
porosity of electrospun fiber meshes, the resulting scaffold has a very low surface density.
As such, this kind of OLE encapsulation is apt for a diffused release. Using electrospun
fibers is thus inherently suitable to provide a sustained low dose delivery of OLE, which
is however combined with architectural cues provided by the fibers to induce tissue
regeneration. We thus investigated if these scaffolds could promote indirect (i.e., cell
mediated) antibacterial activity by assaying the expression of HBD-2. In response to injury
and irritation, epidermal keratinocytes secrete also antimicrobial peptides, along with
cytokines and chemokines [17,56].
The family of β-defensins is composed of small cationic peptides produced by several
cell types, including epithelial cells, Paneth cells, neutrophils and macrophages. These
peptides possess antimicrobial activity and may be secreted constitutively or in response to
microorganisms or cytokines, thus contributing to innate immunity. HBD-2 is an inducible
antimicrobial peptide, reported to act as an endogenous antibiotic against Gram-positive
and Gram-negative bacteria, fungi and the envelope of some viruses. Being released by
epithelial cells, including epidermal keratinocytes, following inflammation, injury or in-
fections, it is involved in the innate immune response of wounds [57]. The capability of
nano/micro-structured materials of inducing HBD-2 expression in HaCaT cells has been
recently reported and is considered very appealing for skin contact applications, including
medical, sanitary and cosmetics [58–61]. In particular, some electrospun fibrous structures
have shown promise in enabling HBD-2 by remarkably upregulating its gene expression
in HaCaT cells already at early time points, i.e., 6 h [27,62]. Among them, PHB/PHOHD
fibers displayed interesting outcomes [27]. In this study, we compared PHB/PHOHD with
commercial PHA, i.e., PHBHV, electrospun fibers produced under the same conditions,
either incorporating or not OLE. Our finding confirmed that PHB/PHOHD fiber meshes,
with and without OLE, can induce HBD-2 upregulation and at the same time can down-
regulate pro-inflammatory cytokines. This capability was not or not sufficiently shown by
OLE alone and PHBHV fibers, with and without OLE.
5. Conclusions
Chronic wounds deriving from ulcers from diabetic, vascular and pressure diseases
represent a healthcare challenge. To produce advanced wound dressings via electrospin-
ning, we investigated different PHAs either incorporating or not OLE. We demonstrated
that OLE can show a different immunomodulatory activity in vitro if administrated directly
or upon release by PHA fiber meshes, turning from pro-inflammatory to anti-inflammatory,
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and even stimulatory of defensin in the case of PHB/PHOHD scaffolds. Such a diverse
behavior can be explained by the longer release time of OLE provided by its incorporation
in the polymer matrices, as well as by the combined effect of the fiber topography and
chemistry, which ultimately appeared prominent. Having a biocompatible and biodegrad-
able scaffold able to suppress inflammation and stimulate innate immune response would
greatly benefit chronic wound care and management.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/app11094006/s1, Figures S1–S3: Chromatograms at 30 min.
Author Contributions: Conceptualization, S.D. and G.D.; methodology, G.D., M.D., K.D.C., I.R. and
R.D.S.; validation, G.D., S.D. and M.D.; formal analysis, S.D. and M.D.; investigation, J.G.D.l.O.,
B.A., A.F. and J.E.S.; resources, M.M., I.R. and A.L.; data curation, J.G.D.l.O., B.A., A.F. and J.E.S.;
writing—original draft preparation, J.G.D.l.O., A.F. and J.E.S.; writing—review and editing, S.D. and
M.D.; visualization, S.D.; supervision, S.D., M.-B.C. and R.D.S.; project administration, S.D.; funding
acquisition, R.D.S., A.L., M.-B.C., I.R. and K.D.C. All authors have read and agreed to the published
version of the manuscript.
Funding: This research was funded by Tuscany region (Pegaso research program) and by the Bio-
Based Industries Joint Undertaking under the European Union Horizon 2020 research program
(BBI-H2020), PolyBioSkin project, grant number G.A. 745839.
Institutional Review Board Statement: Not applicable.
Informed Consent Statement: Not applicable, no study involving humans was performed in this
research.
Data Availability Statement: The data presented in this study are available on request from the
corresponding author. The data are not publicly available since a public repository was not required
for this project.
Acknowledgments: CISUP—Centre for Instrumentation Sharing—University of Pisa is acknowledged.
Conflicts of Interest: The authors declare no conflict of interest.
References
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